PMID- 23621293 OWN - NLM STAT- MEDLINE DCOM- 20140211 LR - 20130628 IS - 1460-2202 (Electronic) IS - 0271-3683 (Linking) VI - 38 IP - 8 DP - 2013 Aug TI - Involvement of NFkappaB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions. PG - 825-34 LID - 10.3109/02713683.2013.780623 [doi] AB - PURPOSE: The purpose of present studies was to determine the involvement of NFkappaB and STAT6 transcription factors in the production of cytokines by the fibroblasts and epithelial cells in conjunctiva. METHODS: An in vitro model of allergic conjunctivitis was developed by sensitizing and challenging rat mast cells with anti-dinitrophenyl (DNP) IgE and DNP-BSA, and then using the conditioned medium to stimulate rat conjunctival fibroblasts. Chemokines (eotaxin-1, IL-8, and RANTES -- Regulated and Normal T cell Expressed and Secreted) released from cells into the medium was determined by ELISA. Human conjunctival fibroblasts and epithelial cells were also directly stimulated with exogenous cytokines tumor necrosis factor (TNF)-alpha or IL-4. Degradation of IkappaB-alpha and phosphorylation of STAT6 were assessed by immunoblotting. For inhibition of NFkappaB or STAT6 activation, upstream regulators IkappaB kinase and Janus protein tyrosine kinases (JAK) were inhibited by use of BMS-345541 and JAK inhibitor 1. An in vivo model of conjunctivitis was also produced in rats by intraperitoneal injection of ovalbumin (OA) with aluminum hydroxide and challenge at 21 d with OA eye drops. RESULTS: Stimulated rat mast cells released TNF-alpha and IL-4. TNF-alpha induced NFkappaB activation in rat and human conjunctival fibroblasts and epithelial cells, and caused production and release of cytokines IL-8 and RANTES. IL-4 activation of STAT6 did not cause release of these cytokines. Only fibroblasts produced the eosinophil-recruiting cytokine, eotaxin-1, after treatment with TNF-alpha- plus IL-4. As observed in the cultured cells, allergic stimulation in the in vivo model caused degradation of IkappaB-alpha in conjunctiva, and infiltration of eosinophils and other inflammatory cells. CONCLUSION: Activated NFkappaB was found to be a major transcription factor for the release of cytokines from conjunctival cells and intensification of the allergic response. Inhibition of the NFkappaB pathway by therapeutic drugs may be an important objective for the treatment of human allergic conjunctivitis. FAU - Sakai, Osamu AU - Sakai O AD - Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co. Ltd., Kobe, Japan. FAU - Tamada, Yoshiyuki AU - Tamada Y FAU - Shearer, Thomas R AU - Shearer TR FAU - Azuma, Mitsuyoshi AU - Azuma M LA - eng PT - Journal Article DEP - 20130426 PL - England TA - Curr Eye Res JT - Current eye research JID - 8104312 RN - 0 (Chemokine CCL11) RN - 0 (Chemokines) RN - 0 (Culture Media, Conditioned) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - 0 (STAT6 Transcription Factor) RN - 0 (Tumor Necrosis Factor-alpha) RN - 207137-56-2 (Interleukin-4) SB - IM MH - Animals MH - Cells, Cultured MH - Chemokine CCL11/immunology/metabolism MH - Chemokines/immunology/*metabolism MH - Conjunctiva/cytology/immunology/*metabolism MH - Conjunctivitis, Allergic/immunology/*metabolism MH - Culture Media, Conditioned/pharmacology MH - Epithelial Cells/cytology/immunology/metabolism MH - Fibroblasts/cytology/immunology/metabolism MH - Interleukin-4/immunology/metabolism MH - Interleukin-8/immunology/metabolism MH - Male MH - Mast Cells/cytology/immunology/metabolism MH - NF-kappa B/immunology/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - STAT6 Transcription Factor/metabolism MH - Tumor Necrosis Factor-alpha/immunology/metabolism EDAT- 2013/04/30 06:00 MHDA- 2014/02/12 06:00 CRDT- 2013/04/30 06:00 PHST- 2013/04/30 06:00 [entrez] PHST- 2013/04/30 06:00 [pubmed] PHST- 2014/02/12 06:00 [medline] AID - 10.3109/02713683.2013.780623 [doi] PST - ppublish SO - Curr Eye Res. 2013 Aug;38(8):825-34. doi: 10.3109/02713683.2013.780623. Epub 2013 Apr 26.